ACTC1 and prostate cancer: Upregulated ACTC1 was reported in various tumors, such as head and neck cancer, bladder cancer, urothelial cancer, prostate cancer (PCa), NSCLC, BC and glioblastoma (GBM), promoting distant metastasis or multi-drug resistance [93].